ESC 365 - Improving outcomes – The current and growing body of evidence for treating both hypertension and high cholesterol.

ESC Premium Access

Improving outcomes – The current and growing body of evidence for treating both hypertension and high cholesterol.

Session: Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol

Topic: Risk scores

Speaker: Professor N. Poulter (London, GB)

Sponsored by Pfizer Inc.

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Neil Poulter

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

27 presentations

0 follower

5 more presentations in this session

Welcome, introduction and objectives - Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol.

Speaker: Professor K. Ray (London, GB)

Assessing global CV risk – Rationale, methods and a global call to action.

Speaker: Professor K. Ray (London, GB)

The burden of hypertension and high cholesterol – Impact of non-compliance and failure to reach goals.

Speaker: Professor R. Rosenson (New York, US)

Panel discussion and Q&A - Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol.

Speaker: Professor K. Ray (London, GB) Professor N. Poulter (London, GB) Professor R. Rosenson (New York, US)

Summary & call to action - Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol.

Speaker: Professor K. Ray (London, GB)

Access the full session

Cardiovascular risk: the dangers of blood pressure and low-density lipoprotein cholesterol

Speakers: Professor N. Poulter, Professor K. Ray, Professor K. Ray, Professor R. Rosenson, Professor K. Ray...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources